XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2020
Earnings (Loss) Per Share  
Earnings (Loss) Per Share

4.    Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings per share:

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2020

    

2019

    

2020

    

2019

(In thousands, except per share amounts)

Numerator:

 

  

 

  

  

 

  

Net earnings (loss)

$

(5,869)

$

6,585

$

(13,590)

$

12,067

 

  

 

  

 

  

 

  

Denominator:

 

  

 

  

 

  

 

  

Basic weighted average shares outstanding

 

9,756

 

9,912

 

9,760

 

9,933

Effect of dilutive securities:

 

  

 

  

 

  

 

  

Employee share-based awards

 

 

17

 

 

63

Diluted weighted average shares outstanding

 

9,756

 

9,929

 

9,760

 

9,996

 

  

 

  

 

  

 

  

Basic earnings (loss) per share

$

(0.60)

$

0.66

$

(1.39)

$

1.21

 

 

 

 

  

Diluted earnings (loss) per share

$

(0.60)

$

0.66

$

(1.39)

$

1.21

The three and nine months ended September 30, 2020, resulted in a net loss; therefore, there was no difference in the weighted average number of common shares for basic and diluted loss per share as the effect of all potentially dilutive shares outstanding was anti-dilutive. Diluted weighted average shares outstanding for the three months ended September 30, 2020, excludes anti-dilutive share-based awards totaling 1,169,000 shares of common stock at a weighted average price of $24.71. Diluted weighted average shares outstanding for the nine months ended September 30, 2020, excludes anti-dilutive share-based awards totaling 1,181,000 shares of common stock at a weighted average price of $26.06. Diluted weighted average shares outstanding for the three months ended September 30, 2019, excludes anti-dilutive share-based awards totaling 1,382,000 shares of common stock at a weighted average price of $26.56. Diluted weighted average shares outstanding for the nine months ended September 30, 2019, excludes anti-dilutive share-based awards totaling 696,000 shares of common stock at a weighted average price of $28.51.